291 related articles for article (PubMed ID: 26512750)
1. Prolactin as an Adjunct for Type 1 Diabetes Immunotherapy.
Hyslop CM; Tsai S; Shrivastava V; Santamaria P; Huang C
Endocrinology; 2016 Jan; 157(1):150-65. PubMed ID: 26512750
[TBL] [Abstract][Full Text] [Related]
2. Prolactin: An Effective Partner for Anti-CD3 in Treating Type 1 Diabetes.
Xiao X
Endocrinology; 2016 Jan; 157(1):39-41. PubMed ID: 26717470
[No Abstract] [Full Text] [Related]
3. Oligofructose as an adjunct in treatment of diabetes in NOD mice.
Chan C; Hyslop CM; Shrivastava V; Ochoa A; Reimer RA; Huang C
Sci Rep; 2016 Nov; 6():37627. PubMed ID: 27874076
[TBL] [Abstract][Full Text] [Related]
4. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.
Besançon A; Goncalves T; Valette F; Dahllöf MS; Mandrup-Poulsen T; Chatenoud L; You S
Diabetologia; 2018 Feb; 61(2):389-398. PubMed ID: 29030662
[TBL] [Abstract][Full Text] [Related]
5. Intestinal Delivery of Proinsulin and IL-10 via
Cook DP; Cunha JPMCM; Martens PJ; Sassi G; Mancarella F; Ventriglia G; Sebastiani G; Vanherwegen AS; Atkinson MA; Van Huynegem K; Steidler L; Caluwaerts S; Rottiers P; Teyton L; Dotta F; Gysemans C; Mathieu C
Front Immunol; 2020; 11():1103. PubMed ID: 32582188
[TBL] [Abstract][Full Text] [Related]
6. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
Sherry NA; Chen W; Kushner JA; Glandt M; Tang Q; Tsai S; Santamaria P; Bluestone JA; Brillantes AM; Herold KC
Endocrinology; 2007 Nov; 148(11):5136-44. PubMed ID: 17673522
[TBL] [Abstract][Full Text] [Related]
7. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin mitigates β-cell mass loss during insulitis in an animal model of autoimmune diabetes mellitus, the BioBreeding/Worcester rat.
Baena-Nieto G; Lomas-Romero IM; Mateos RM; Leal-Cosme N; Perez-Arana G; Aguilar-Diosdado M; Segundo C; Lechuga-Sancho AM
Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27103341
[TBL] [Abstract][Full Text] [Related]
9. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
Reddy S; Cheung CC; Chai RC; Rodrigues JA
Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
[TBL] [Abstract][Full Text] [Related]
10. Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation.
Sasaki H; Yasuda H; Moriyama H; Nakamura A; Shimizu M; Arai T; Nagata M; Hara K; Yokono K
Biochem Biophys Res Commun; 2011 May; 408(2):306-11. PubMed ID: 21513702
[TBL] [Abstract][Full Text] [Related]
11. Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area.
Xue S; Wasserfall C; Parker M; McGrail S; McGrail K; Campbell-Thompson M; Schatz DA; Atkinson MA; Haller MJ
J Diabetes Complications; 2010; 24(3):163-7. PubMed ID: 19217320
[TBL] [Abstract][Full Text] [Related]
12. Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice.
Ding L; Gysemans CA; Stangé G; Heremans Y; Yuchi Y; Takiishi T; Korf H; Chintinne M; Carr RD; Heimberg H; Pipeleers D; Mathieu C
PLoS One; 2014; 9(9):e107935. PubMed ID: 25268801
[TBL] [Abstract][Full Text] [Related]
13. Biphasic decline of β-cell function with age in euglycemic nonobese diabetic mice parallels diabetes onset.
Cechin SR; Lopez-Ocejo O; Karpinsky-Semper D; Buchwald P
IUBMB Life; 2015 Aug; 67(8):634-44. PubMed ID: 26099053
[TBL] [Abstract][Full Text] [Related]
14. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
Bergerot I; Fabien N; Thivolet C
Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
[TBL] [Abstract][Full Text] [Related]
15. Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming.
Villalba A; Rodriguez-Fernandez S; Perna-Barrull D; Ampudia RM; Gomez-Muñoz L; Pujol-Autonell I; Aguilera E; Coma M; Cano-Sarabia M; Vázquez F; Verdaguer J; Vives-Pi M
Front Endocrinol (Lausanne); 2020; 11():258. PubMed ID: 32477262
[TBL] [Abstract][Full Text] [Related]
16. Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?
O'Kell AL; Wasserfall C; Catchpole B; Davison LJ; Hess RS; Kushner JA; Atkinson MA
Diabetes; 2017 Jun; 66(6):1443-1452. PubMed ID: 28533295
[TBL] [Abstract][Full Text] [Related]
17. Beta Cell Mass Restoration in Alloxan-Diabetic Mice Treated with EGF and Gastrin.
Song I; Patel O; Himpe E; Muller CJ; Bouwens L
PLoS One; 2015; 10(10):e0140148. PubMed ID: 26452142
[TBL] [Abstract][Full Text] [Related]
18. Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice.
Gagliani N; Jofra T; Posgai AL; Atkinson MA; Battaglia M
PLoS One; 2015; 10(11):e0142318. PubMed ID: 26580221
[TBL] [Abstract][Full Text] [Related]
19. Prolactin protects against diabetes induced by multiple low doses of streptozotocin in mice.
Holstad M; Sandler S
J Endocrinol; 1999 Nov; 163(2):229-34. PubMed ID: 10556772
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
